Showing 1 to 10 of 23 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7 NCT03550391  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Brain |
Dr. David Roberge Mom Phat 514-890-8000 poste 11171 |
|
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
NRG-BN003 NCT03180268 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Bassam Abdulkarim Ginette Ricard 514-934-1934 poste 43186 |
|
A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy
Orbus OT-15-0011 NCT02796261 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL NEUROLOGIQUE DE MONTREAL
|
Brain |
Dr. Kevin Petrecca Gabriele Riva 514-398-6907 |
|
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme
INTRAGO II NCT02685605 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL NEUROLOGIQUE DE MONTREAL
|
Brain |
Dr. Kevin Petrecca Gabriele Riva 514-398-6907 |
|
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
BN001 NCT02179086 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Valérie Panet-Raymond Marie-Claude Joncas 514-934-1934 poste 34906 |
|
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
BN001 NCT02179086 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Brain |
Dr. Nathalie Lessard Josée Allard 418-525-4444 poste 16730 |
|
A Phase II Study in Relapsing Glioblastoma of Intraarterial Concurrent Chemoradiation Therapy Using IA Carboplatin
2018-2452 NCT03672721 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Brain |
Dr. David Fortin Marie-Andrée Roy 819-346-1110 poste 13895 |
|
Metformin and Neo-adjuvant Temozolomide and Hypofractionated Accelerated Limited-margin Radiotherapy Followed by Adjuvant Temozolomide in Patients With Glioblastoma Multiforme
MUHC ID: 4315 (M-HARTT STUDY) NCT02780024 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. George Shenouda Marianna Perna 514-934-1934 poste 43191 |
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7 NCT03550391 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Valérie Panet-Raymond Evelyn Ortega 514-934-1934 poste 48354 |
|
Phase III Randomized Double-blind Placebo-controlled Trial of Metformin for Cognitive Recovery and White Matter Growth in Paediatric Medulloblastoma Patients
Met Med Can NCT05230758 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Brain |
Dr. Valérie Larouche Panagiota Giannakouros 418-525-4444 poste 40121 |
Groupe d'étude en oncologie du Québec